Literature DB >> 7082532

Maternal kinetics and transplacental passage of pethidine during labour.

G Tomson, R I Garle, B Thalme, H Nisell, L Nylund, A Rane.   

Abstract

1 Pethidine is commonly used in single doses as an analgesic in obstetrics. Plasma concentration-time profiles of pethidine after intramuscular administration of 1.5 mg/kg body weight to 16 pregnant women during labour were investigated. There was only a two-fold variation in peak plasma concentration (300-650 ng/ml). The mean (+/- s.d.) value of the apparent plasma half-life of pethidine was 3.4 (+/- 1.0) h which is not different from that in healthy controls. norpethidine plasma levels were not measurable (less than 10 ng/ml). 2 The placental transfer transfer of pethidine was studied at delivery in samples from the umbilical cord vessels and from a maternal peripheral vein. In another 14 patients serial determinations of pethidine concentration were made in foetal scalp blood and maternal venous blood simultaneously during the different stages of labour. The foeto-maternal drug ratio varied between 0.35 and 1.5 with a positive correlation between ratio and dose delivery time interval. The concentration of pethidine in umbilical cord plasma or blood varied between 60 and 400 ng/ml with dose-delivery time intervals of 30 min to 10.5 h. The foetal concentration of pethidine reached a peak-plateau value between 1-5 h after dose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082532      PMCID: PMC1402094          DOI: 10.1111/j.1365-2125.1982.tb01432.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  32 in total

1.  The clinical pharmacology of meperidine--comparison of routes of administration.

Authors:  J E Stambaugh; I W Wainer; J K Sanstead; D M Hemphill
Journal:  J Clin Pharmacol       Date:  1976 May-Jun       Impact factor: 3.126

2.  Letter: Pharmacokinetics of meperidine in man.

Authors:  G Moore; R Nation
Journal:  Clin Pharmacol Ther       Date:  1976-04       Impact factor: 6.875

3.  The effect of cirrhosis on the disposition and elimination of meperidine in man.

Authors:  U Klotz; T S McHorse; G R Wilkinson; S Schenker
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

4.  Blood concentrations of pethidine and pentazocine in mother and infant at time of birth.

Authors:  A H Beckett; J F Taylor
Journal:  J Pharm Pharmacol       Date:  1967-12       Impact factor: 3.765

5.  Obstetric premedication and infant outcome.

Authors:  Y Brackbill; J Kane; R L Manniello; D Abramson
Journal:  Am J Obstet Gynecol       Date:  1974-02-01       Impact factor: 8.661

6.  Metabolites of meperidine related to fetal depression.

Authors:  J C Morrison; W L Wiser; S I Rosser; J O Gayden; E T Bucovaz; W D Whybrew; S A Fish
Journal:  Am J Obstet Gynecol       Date:  1973-04-15       Impact factor: 8.661

7.  The placental transfer of pentazocine and pethidine.

Authors:  J Moore; T G McNabb; J P Glynn
Journal:  Br J Anaesth       Date:  1973-07       Impact factor: 9.166

8.  The placental transmission of pethidine.

Authors:  J S Crawford; S Rudofsky
Journal:  Br J Anaesth       Date:  1965-12       Impact factor: 9.166

9.  Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers.

Authors:  L E Mather; G T Tucker; A E Pflug; M J Lindop; C Wilkerson
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

10.  Pethidine revisited: plasma concentrations and effects after intramuscular injection.

Authors:  L E Mather; M J Lindop; G T Tucker; A E Pflug
Journal:  Br J Anaesth       Date:  1975-12       Impact factor: 9.166

View more
  5 in total

Review 1.  The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.

Authors:  M D Hill; F P Abramson
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 2.  The Placental Barrier: the Gate and the Fate in Drug Distribution.

Authors:  Nino Tetro; Sonia Moushaev; Miriam Rubinchik-Stern; Sara Eyal
Journal:  Pharm Res       Date:  2018-02-23       Impact factor: 4.200

3.  Maternal and fetal effects of intravenous patient-controlled fentanyl analgesia during labour in a thrombocytopenic parturient.

Authors:  O P Rosaeg; J B Kitts; G Koren; L J Byford
Journal:  Can J Anaesth       Date:  1992-03       Impact factor: 5.063

Review 4.  Obstetric analgesia. Clinical pharmacokinetic considerations.

Authors:  J Kanto
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

5.  Extradural and parenteral pethidine as analgesia after total hip replacement: effects and kinetics. A controlled clinical study.

Authors:  L L Gustafsson; J Johannisson; M Garle
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.